Exaggerated secretion of glucagon-like peptide- 1 (GLP-1) could cause reactive hypoglycaemia

Diabetologia

Volumn 41, Issue 10, 1998, Pages 1180-1186

  Toft Nielsen, M ^a,b   Madsbad, S ^a   Holst, J J ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Gastrectomy; Glucagon; Glucose dependent insulinotropic peptide (GIP); Insulin; Late dumping

Indexed keywords

GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN;

ADULT; ARTICLE; FEMALE; GASTRECTOMY; HUMAN; HUMAN EXPERIMENT; HYPOGLYCEMIA; MALE; POSTGASTRECTOMY SYNDROME; PRIORITY JOURNAL; SECRETION; STOMACH EMPTYING;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; DUMPING SYNDROME; FEMALE; GASTRECTOMY; GASTRIC EMPTYING; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; HYPOGLYCEMIA; KINETICS; MALE; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS;

EID: 0031721391     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051049     Document Type: Article

References (40)

1. Roth DA, Maede RC (1965) Hyperinsulinism-hypoglycemia in the postgastrectomy patient. Diabetes 14: 526-528
2. Shultz KT, Neelon FA, Nilsen LB, Lebovitz HE (1971) Mechanism of postgastrectomy hypoglycemia. Arch Intern Med 128: 240-246
3. Hocking MP, Vogel SB (1991) Woodward's postgastrectomy Syndromes. 2nd edn. WB Saunders Company, Philadelphia
4. Lawaetz O, Aritas Y, Blackburn AM, Ralphs DNL (1982) Gastric emptying after peptic ulcer surgery. Scand J Gastroenterol 17: 1065-1072
5. Amdrup E, Hjorth P, Jørgensen JB (1958) Radiologic demonstration of variations in the fluid content of the small intestine during dumping attacks. Br J Radiol 31: 542-548
6. Duthie HL, McKellar NJ (1960) Radiological appearances in the post-gastrectomy dumping syndrome. Br J Radiol 33: 171-177
7. Christoffersen E, Kewenter J, Kock NG (1962) Intestinal motility during provoked dumping reaction. Acta Chir Scand 123: 405-414
8. Holdsworth CD, Turner D, McIntyre N (1969) Pathophysiology of post-gastrectomy hypoglycaemia. BMJ 4: 257-259
9. McIntyre N, Holdsworth CD, Turner DS (1965) Intestinal factors in control of insulin secretion. J Clin Endocrinol Metab 25: 1317-1324
10. Miholic J, Ørskov C, Holst JJ, Kotzerke J, Meyer HJ (1991) Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1). and reactive hypoglycemia after total gastrectomy. Dig Dis Sci 36: 1361-1370
11. Andreasen JJ, Ørskov C, Holst JJ (1994) Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy. Digestion 55: 221-228
12. Kreymann B, Ghatei MA, Williams G, Bloom SR (1987) Glucagon-like peptide-1 7-36: a physiologic incretin in man. Lancet ii:1300-1304
13. Lawaetz O, Blackburn AM, Bloom SR, Aritas Y, Ralphs DNL (1983) Gut hormone profile and gastric emptying in the dumping syndrome. Scand J Gastroenterol 18: 73-80
14. Schattenmann G, Ebert R, Siewert R, Creutzfeldt W (1984) Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum. Gastroenterol 19: 260-266
15. Jorde R, Schulz TB, Burhol PG, Schulz LB (1981) The response of plasma gastric-inhibitory polypeptide (GIP) to slow and fast glucose ingestion in Billroth II resected patients and normal controls. Regul Pept 2: 391-239
16. Thromford NR, Sirinek KR, Crockett SE, Mazzaferri EL, Cataland S (1974) Gastric inhibitory polypeptide. Arch Surg 109:177-182
17. Miholic J, Ørskov C, Holst JJ, Kotzerke J, Pichlmayr R (1993) Postprandial release of glucagon-like peptide-1, pancreatic glucagon, and insulin after esophageal resection. Digestion 54: 73-78
18. Schirra J, Katschinski M, Weidmann C et al. (1996) Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 97: 92-103
19. Qualmann C, Nauck MA, Holst JJ, Ørskov C, Creutzfeldt W (1995) Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7-36 amide] in the fasting state in healthy subjects. Acta Diabetol 32: 13-16
20. Nauck M, Schmidt WE, Ebert R et al. (1989) Insulinotropic properties of synthetic human gastic inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8. J Clin Endocrinol Metab 69: 654-662
21. Albano JDM, Ekins RP, Maritz G, Turner RC (1972) A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol 70: 487-509
22. Ørskov C, Jeppesen J, Madsbad S, Holst JJ (1991) Proglucagon products in plasma from non-insulin dependent diabetics and non-diabetic controls in the fasting state and following oral glucose and intravenous arginine. J Clin Invest 87: 415-423
23. Ørskov C, Rabenhøj L, Kofod H, Wettergren A, Holst JJ (1994) Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide-1 in humans. Diabetes 43: 535-539
24. Krarup T, Madsbad S, Moody AJ et al. (1983) Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics. J Clin Endocrinol Metab 56: 1306-1312
25. Krarup T, Holst JJ (1984) The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera. Regul Pept 9: 35-46
26. Ritzel R, Ørskov C, Holst JJ, Nauck MA (1995) Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationships. Diabetologia 38: 720-725
27. Nauck MA, Bartels E, Ørskov C, Ebert R, Creutzfeldt W (1993) Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1 (7-36) amide infused at near-physiological insulinotropic and glucose concentrations. J Clin Endocrinol Metab 76: 912-917
28. Gromada J, Bokvist K, Ding W, Holst JJ, Nielsen JH, Rorsman P (1998) Glucagon-like Peptide-1(7-36) amide stimulates exocytosis in human pancreatic β-cells by both proximal and distal regulatory steps in the stimulus-secretion coupling. Diabetes 47: 57-65
29. Ørskov C (1992) Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia 35: 701-711
30. Gromada J, Holst JJ, Rorsman P (1998) Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide-1. Eur J Physiol 435: 583-594
31. Toft-Nielsen M, Madsbad S, Holst JJ (1996) The effect of glucagon-like peptide-1 (GLP-1) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones. Diabetes 45: 552-556
32. Ørskov L, Holst JJ, Møller J et al. (1996) GLP-1 does not acutely affect insulin sensitivity in healthy man. Diabetologia 39: 1227-1232
33. Prager P, Wallace P, Olefsky JM (1986) In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest 78: 472-481
34. Krarup T, Nürnberg B, Mikkelsen K, Astrup A, Madsbad S, Holst JJ (1990) How arterialized is blood from a heated superficial vein? Diabetes 39 [Suppl 1]88A (Abstract)
35. Gutniak M, Ørskov C, Holst JJ, Ahrén B, Efendic S (1992) Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus. N Engl J Med 236: 1316-1322
36. Nauck MA, Heimesaat MM, Ørskov C, Holst JJ, Ebert R, Creutzfeldt W (1993) Preserved incretin activity of glucagon-like peptide-1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with Type-2 diabetes mellitus. J Clin Invest 91: 301-307
37. Nauck MA, Kleine N, Holst JJ, Willms B, Creutzfeldt W (1993) Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide-1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36: 741-744
38. Creutzfeldt W, Talaulicar M, Ebert R, Willms B (1980) Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes. Diabetes 29: 140-145
39. Hermann-Rinke C, Vöge A, Hess M, Göke B (1995) Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides. J Endocrinol 147: 25-31
40. Roberge JN, Brubaker PL (1993) Regulation of proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 133: 233-240